Tag: regulatory science

AI, ML and Automation Use-Cases That Unlock Value in Sustainable & Green R&D Practices The integration of artificial intelligence (AI), machine learning (ML), and automation into pharmaceutical research and development offers groundbreaking advantages that enhance sustainable practices. These technologies not only improve efficiency and accuracy but also promote environmentally friendly and socially responsible research methodologies….

Read More “AI, ML and Automation Use-Cases That Unlock Value in Sustainable & Green R&D Practices” »

Risk Management and Stage-Gate Governance for Sustainable & Green R&D Practices Introduction to Risk Management in Clinical Trials Risk management is a crucial aspect of clinical trials, especially when considering the principles of sustainability and green practices. It involves identifying, assessing, and mitigating risks associated with clinical research. In the context of pharmaceutical research and…

Read More “Risk Management and Stage-Gate Governance for Sustainable & Green R&D Practices” »

IP, Exclusivity and Deal-Making Implications of Strong Sustainable & Green R&D Practices IP, Exclusivity and Deal-Making Implications of Strong Sustainable & Green R&D Practices Introduction to Sustainable & Green R&D in Clinical Trials As the pressures on the pharmaceutical industry increase due to climate change and social responsibility, the integration of sustainable and green practices…

Read More “IP, Exclusivity and Deal-Making Implications of Strong Sustainable & Green R&D Practices” »

Sustainability, ESG and Green R&D Considerations in Sustainable & Green R&D Practices Sustainability, ESG and Green R&D Considerations in Sustainable & Green R&D Practices Introduction to Sustainable R&D Practices Sustainable Research and Development (R&D) practices are becoming increasingly critical in the pharmaceutical industry. Factors such as environmental sustainability, social responsibility, and strong governance (ESG) have…

Read More “Sustainability, ESG and Green R&D Considerations in Sustainable & Green R&D Practices” »

Roadmap: 12–24 Month Plan to Upgrade Your Organization’s Sustainable & Green R&D Practices The pharmaceutical industry’s increasing emphasis on sustainability calls for organizations to adopt green research and development (R&D) practices. With regulatory bodies such as the FDA, EMA, and MHRA gradually directing focus toward sustainable practices, this guide provides a comprehensive 12-to-24 month plan…

Read More “Roadmap: 12–24 Month Plan to Upgrade Your Organization’s Sustainable & Green R&D Practices” »

How Sustainable & Green R&D Practices Supports Precision Medicine and Biomarker-Driven Trials How Sustainable & Green R&D Practices Supports Precision Medicine and Biomarker-Driven Trials Introduction to Sustainable R&D Practices Clinical trials are at the forefront of advancing healthcare and medical research. With the emergence of precision medicine and biomarker-driven trials, the focus has shifted not…

Read More “How Sustainable & Green R&D Practices Supports Precision Medicine and Biomarker-Driven Trials” »

Emerging Science and Technology Trends Redefining Sustainable & Green R&D Practices Introduction to Sustainable R&D in Clinical Trials The landscape of pharmaceutical research and development (R&D) is undergoing a transformative shift towards sustainability, aligning with global initiatives aimed at reducing environmental impact. As clinical trials become an essential component of this transformation, understanding the integration…

Read More “Emerging Science and Technology Trends Redefining Sustainable & Green R&D Practices” »